Stockreport

FDA to review Intellipharmaceutics' NDA for abuse-deterrent oxycodone; shares ahead 10% after hours [Seeking Alpha]

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com
PDF Thinly traded nano cap Intellipharmaceutics (NASDAQ: IPCI ) is up   after hours on increased volume in response to its announcement that the FDA has accepted fo [Read more]